The IL-23/IL-17 pathway is critical in several autoimmune diseases, including psoriatic skin inflammation, inflammatory bowel disease, experimental autoimmune encephalitis and autoimmune myocarditis [123, 124]. Here, IL17A is linked to inflammatory bowel disease.